InvestorsHub Logo
Followers 4
Posts 1012
Boards Moderated 0
Alias Born 02/14/2017

Re: bzlegendz post# 5498

Tuesday, 12/19/2017 9:23:36 AM

Tuesday, December 19, 2017 9:23:36 AM

Post# of 21531
Both investment and scientific presentations. We will see if this gets NRTP the credibility it deserves.

Details of the Company presentation at the 10th Annual Biotech Showcase Conference are as follows:

Title: Neurotrope Corporate Presentation
Date/Time: Monday, January 8, 2018; 11:30am PT/ 2:30pm ET
Location: Hilton San Francisco, Union Square, Yosemite B Ballroom Level

“We look forward to sharing the additional findings from our Phase 2 bryostatin trial with our scientific and industry peers,” said Daniel Alkon, MD, President and Chief Scientific Officer at Neurotrope. “Based on our data analysis, we now have greater insights into the potential clinical benefits of bryostatin that will guide our ongoing development of this agent for Alzheimer’s disease and other neurodegenerative disorders.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News